Search Results 731-740 of 18705 for hepatitis

  1. Engineering stem cells to treat liver disease - Mayo Clinic News Network

    While the liver has a remarkable ability to regenerate, chronic conditions such as cirrhosis, hepatitis and fatty liver disease can quickly progress to end- ...

  2. A Study to Evaluate Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

    Active hepatitis B virus (HBV) or hepatitis C virus infection that requires treatment or at risk for HBV reactivation. At risk for HBV reactivation is ...

  3. PR3-AAV Resilient Remission or PRRR - Clinical Trials

    - Infection (blood borne): active hepatitis B or active hepatitis C or a documented history of HIV, hepatitis B, or hepatitis C. - Infection (history): ...

  4. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

    Has active or uncontrolled hepatitis B or C infection; subject is positive for hepatitis ... hepatitis B (hepatitis B virus surface antigen [HBsAg] ...

  5. A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 in Amyotrophic Lateral Sclerosis (ALS) Patients - Mayo Clinic

    Current hepatitis B infection (defined as positive for hepatitis B surface antigen [HBsAg] and/or total hepatitis B core antibody [anti-HBc]). Participants ...

  6. Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer - Mayo Clinic

    ... hepatitis B (chronic or acute) or hepatitis C infection. Patients with past or resolved hepatitis B infection (defined as having a negative hepatitis B ...

  7. Esophageal varices - Doctors and departments - Mayo Clinic

    ... hepatitis, Autoimmune hepatitis, Hepatocellular carcinoma, Wilson's disease, Hepatopulmonary syndrome, Primary biliary cholangitis, Portopulmonary ...

  8. Infliximab-qbtx (intravenous route) - Mayo Clinic

    Hepatitis B, active or history of or; Histoplasmosis (fungus infection) ... This medicine may increase your chance of having a lupus-like syndrome or a liver ...

  9. A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Cirrhosis- FALCON 1 Study - Mayo Clinic

    Other causes of liver disease (e.g., alcoholic liver disease, hepatitis B virus infection, chronic hepatitis C virus infection, autoimmune hepatitis, drug ...

  10. A Study to Evaluate ADP-A2M4 with Pembrolizumab to Treat Recurrent or Metastatic Head and Neck Cancer - Mayo Clinic

    Active hepatitis B infection as demonstrated by test for hepatitis B surface antigen. Subjects who are hepatitis B surface antigen negative but are hepatitis ...